Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 USD | -1.32% | -4.76% | -9.64% |
12/04 | Piper Sandler Adjusts Price Target on Century Therapeutics to $9 From $10, Maintains Overweight Rating | MT |
11/04 | Syncona agrees to sell stake in investee company for GBP7.4 million | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.64% | 247M | |
+26.28% | 48.09B | |
+47.70% | 40.62B | |
-3.99% | 40.43B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.02% | 11.88B | |
-2.75% | 11.8B |
- Stock Market
- Equities
- IPSC Stock
- News Century Therapeutics, Inc.
- Century Therapeutics : Outpace Bio Enter Cell Therapy Research Collaboration